JG
IMNM icon

Joel Greenblatt’s Immunome IMNM Stock Holding History

Joel Greenblatt’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214K Hold
10,100
– – ﹤0.01% 1720
2026
Q1 		$221K Hold
10,100
– – ﹤0.01% 1670
2025
Q4 		$217K Sell
10,100
-100
-1% -$1.75K ﹤0.01% 1642
2025
Q3 		$119K Hold
10,200
– – ﹤0.01% 1644
2025
Q2 		$94.9K Hold
10,200
– – ﹤0.01% 1618
2025
Q1 		$68.6K Buy
+10,200
New +$97.9K ﹤0.01% 1523

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Joel Greenblatt's IMNM Position: Q2 2026 in Review

Joel Greenblatt held its Immunome (IMNM) position steady in Q2 2026 at 10,100 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

Joel Greenblatt first reported a position in IMNM in Q1 2025 and has held it in 6 quarters since. The position peaked at $221K in Q1 2026. 200 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Joel Greenblatt held 10,100 shares of Immunome worth $214K as of Q2 2026.
  • Joel Greenblatt left its Immunome share count unchanged in Q2 2026.
  • Immunome made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1720 holding.
  • Joel Greenblatt first reported a position in Immunome in Q1 2025 and has held it in 6 quarters since.
  • Joel Greenblatt's Immunome position peaked at $221K in Q1 2026.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.